Pressemitteilung: PAIONs innovatives Sedativum/Anästhetikum CNS 7056 erreicht Zielprofil in Proof-of-Concept-Studie im Menschen
Download (26 KB)
Copyright © 2001 - 2012 PAION AG. All rights reserved. E-Mail: info@paion.com

Download (26 KB)
Copyright © 2001 - 2012 PAION AG. All rights reserved. E-Mail: info@paion.com